Why We Race
Join the Fight
On August 17, 2019, the 21st Annual Mitchell’s Run Thru Rockford (MRTR), a 5K Run/Walk and Kids for Kids Fun Run will take place in downtown Rockford. 100% of the race fees and pledges from this event are donated to Parent Project Muscular Dystrophy (PPMD).
PPMD’s mission is to end Duchenne muscular dystrophy, a fatal genetic disorder that slowly robs people of their muscle strength. Those with Duchenne are truly in a race against time as their muscles deteriorate further each day. When you join Mitchell’s Run thru Rockford, a Race to End Duchenne, you are supporting PPMD's vital work in advancing research, care, and advocacy to help those with Duchenne live longer, stronger lives.
Duchenne is the most common muscular dystrophy in children. It is a progressive disorder that causes muscles to become weaker over time until it affects the whole body. Duchenne is not contagious. About one out of every 5,000 boys has Duchenne, and about 20,000 babies worldwide are born with it each year. Duchenne mostly affects boys and reaches across all races and cultures. Parent Project Muscular Dystrophy (PPMD) estimates that there are about 15,000 young men, as well as a few young women, living with Duchenne today in the United States.
Over the past 20 years, MRTR has included over 10,000 participants, 1,000 volunteers, and several thousand spectators, raising over $1,000,000. Mitchell’s Run Thru Rockford has been designated by Classic Race Management as “One of the Premier Running Events in West Michigan”.
Mitchell Peterson, age 23, attending MRTR 2018. Mitchell was diagnosed with Duchenne shortly before his 3rd birthday.
The goal of MRTR 2019 is to raise additional funding to be donated to PPMD in honor of Mitchell and the dozens of other children with Duchenne from West Michigan (Tyler, Alec, Kyle, Brody, Chase, Jared, Nathan, Markie, Ben, Nicholas, Lucas, Colin and many more).
Everything PPMD does —and everything they have done since their founding in 1994—helps those with Duchenne live longer, stronger lives. They will not rest until they end Duchenne for every single person affected by the disease.
PPMD fights to end Duchenne. All research through Parent Project Muscular Dystrophy is directed and focused on Duchenne and Becker muscular dystrophy. Duchenne is a fatal genetic disorder that slowly robs people of their muscle strength. PPMD fights every single battle necessary to end Duchenne: They accelerate research, raise community voices to impact policy, demand optimal care standards, ensure every family has access to expert healthcare providers, cutting edge treatments, and a community of support. They invest deeply in treatments for this generation of Duchenne patients and in research that will benefit future generations. Their advocacy efforts have secured hundreds of millions of dollars in funding and won two FDA approvals.